Stock Screener ETF Screener

Penny Stock Screener Technical Analysis Screener

Dividend Center Best Dividend Stocks

Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison

Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Trending News

Education

Personal Finance How To Use TipRanks TipRanks Labs Glossary FAQs

About Us

About TipRanks Contact Us Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

Follow Us

TOOLS

Top Insiders Stocks

Notification Center

Penny Stock Screener

Technical Analysis Screener

Top Analyst Stocks

Top Smart Score Stocks

AI Analyst Top Stocks

Top Insiders Stocks

Trending Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

Top Gainers/losers/active ETFs

Trump Dashboard

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Earnings Calendar

Dividend Calendar

Economic Calendar

Market Holidays

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Private Companies

Personal Finance Center

Investing & Retirement

Spending & Savings

Top Online Brokers

Enterprise Solutions

Plans & Pricing

Education

How To Use TipRanks

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

TipRanks News Wire

Follow Us

STOCKS

pc:strmb

STRMBIO

Research Platforms

STRM.BIO is a biotechnology company developing a non-viral, cell-derived delivery modality that enables safe, targeted, and scalable in vivo delivery of genetic medicines. Its megakaryocyte-derived vesicle (MV) platform focuses on non-viral gene delivery for hematological diseases and in vivo immune and hematopoietic cell engineering, enabling applications in gene editing, RNA therapeutics, and immune cell engineering.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation―

Estimated Valuation―

Total Amount Raised$8M

Total Amount Raised$8M

Total Funding Rounds1

Total Funding Rounds1

Latest Funding Amount$8M

Latest Funding Amount$8M

Latest Funding RoundSeed Round

Latest Funding RoundSeed Round

Post-Money Valuation―

Post-Money Valuation―

Funding Round

Jan 07, 2026

Seed Round

$8.00M

―

Investors

Seed Round

Seed Round

Boehringer Ingelheim Ventures

Seed Round

Blue Bay Capital Fund

Seed Round

Related News and Analysis

Flexzo Ai Signs Multi-Year Deal to Power Island Doctors’ AI-Driven Staffing Across Florida Clinics

Flexzo Ai Signs Multi-Year Deal to Power Island Doctors’ AI-Driven Staffing Across Florida Clinics

New updates have been reported about Flexzo AI. Flexzo Ai has secured a multi-year, multi-site agreement to deploy...

2h ago

Flexzo Ai Wins Nao Medical Deal to Power Data-Driven Clinician Hiring and Deployment

Flexzo Ai Wins Nao Medical Deal to Power Data-Driven Clinician Hiring and Deployment

New updates have been reported about Flexzo AI. Flexzo Ai has secured a strategic partnership with Nao Medical,...

2h ago

AG1 Backs Penn State Research on Nutrition and GLP-1 Medication Use

AG1 Backs Penn State Research on Nutrition and GLP-1 Medication Use

According to a recent LinkedIn post from AG1, the company is highlighting rapid growth in GLP-1 medication use...

3h ago

Harvey Expands APAC Presence With Singapore Office and Legal-Sector Engagement

Harvey Expands APAC Presence With Singapore Office and Legal-Sector Engagement

According to a recent LinkedIn post from Harvey, the company is building momentum across the Asia-Pacific region, with...

3h ago

Apono Highlights Zero-Standing-Privilege Focus Ahead of RSA 2026

Apono Highlights Zero-Standing-Privilege Focus Ahead of RSA 2026

According to a recent LinkedIn post from Apono, the company is promoting its presence at the RSA 2026...

3h ago

Sakana AI Expands Focus on Defense and Intelligence Analytics With Narrative-Extraction Technology

Sakana AI Expands Focus on Defense and Intelligence Analytics With Narrative-Extraction Technology

According to a recent LinkedIn post from Sakana AI, the company collaborated with Yomiuri Shimbun to analyze China-originated...

3h ago

Simpro Software Highlights AI-Driven Focus on Review Management for Contractors

Simpro Software Highlights AI-Driven Focus on Review Management for Contractors

A LinkedIn post from Simpro Software highlights an upcoming webinar focused on how online reviews influence commercial contracting...

3h ago

ConverzAI Targets Staffing Industry Decision Makers With Agentic AI Positioning

ConverzAI Targets Staffing Industry Decision Makers With Agentic AI Positioning

A LinkedIn post from ConverzAI highlights the participation of CEO and founder Ashwarya Poddar in an interactive roundtable...

3h ago

GMI Cloud Hosts Singapore AI DevHack to Build Developer Ecosystem

GMI Cloud Hosts Singapore AI DevHack to Build Developer Ecosystem

According to a recent LinkedIn post from GMI Cloud, the company is organizing a one-day DevHack event in...

3h ago

Replit Targets Developer Growth With Agent 4 Buildathon Initiative

Replit Targets Developer Growth With Agent 4 Buildathon Initiative

According to a recent LinkedIn post from Replit, the company is promoting an “Agent 4 Buildathon,” a three-week...

3h ago